Related Experiment Video
Updated: May 11, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
IMMUNOLOGICAL AND VIROLOGIC OUTCOMES WITHIN TEN YEARS OF COMBINED ANTIRETROVIRAL THERAPY INITIATED BEFORE ONE YEAR OF
Francis Ateba Ndongo1, Mathurin Cyrille Tejiokem2, Calixte Ida Penda3
1MD,PhD, University of Garoua; Centre Mère et Enfant de la Fondation Chantal Biya; Ministry of Public Health; Yaounde, Cameroon;
Insights
Early combined Antiretroviral Therapy (cART) in children with perinatal HIV shows long-term benefits but is hampered by initial high mortality. Early infant HIV screening is crucial to improve outcomes and prevent advanced disease.
Area of Science:
- Pediatric Infectious Diseases
- HIV/AIDS Research
- Public Health in Sub-Saharan Africa
Background:
- Perinatal HIV infection presents significant long-term health challenges for children.
- Early initiation of combined Antiretroviral Therapy (cART) is critical for managing pediatric HIV.
- Understanding long-term outcomes of early cART in resource-limited settings is essential.
Purpose of the Study:
- To evaluate immunological and virologic outcomes within 10 years of early cART initiation in Cameroonian children with perinatal HIV.
- To identify factors associated with long-term treatment success in this population.
- To inform public health strategies for pediatric HIV management.
Main Methods:
- Prospective cohort study conducted in 3 referral hospitals in Cameroon.
- Time-to-event analysis used to assess probabilities of viral suppression, sustained viral suppression, immunocompetence, and mortality.
- Data collected on demographics, treatment regimens, and home conditions.
Main Results:
- At 10 years, an estimated 22.0% mortality occurred, primarily in the first two years due to advanced HIV disease.
- Viral suppression (VS) was achieved by 72.0% of children, with 70.0% maintaining it.
- Immunocompetence increased significantly from 45.3% at baseline to 88.6% at 10 years.
- Receiving ritonavir-boosted lopinavir (LPV/r)-based regimens and baseline immunocompetence were associated with sustained VS.
Conclusions:
- High early mortality significantly impairs the long-term efficacy of early cART in children with perinatal HIV.
- Community-based screening strategies are vital for early HIV detection in infants before advanced disease develops.
- Optimizing treatment regimens and early intervention are key to improving long-term survival and health in vertically infected children.
Background:
We reported immunological and virologic outcomes within 10 years of combined Antiretroviral Therapy (cART) initiated no later than age one year and associated factors in children with perinatal HIV in Cameroon.
Setting:
This study was conducted in 3 referral hospitals in Cameroon.
Methods:
We conducted a prospective cohort study, using time-to-event analysis. Probabilities of the following outcomes were assessed within the first 10 years of cART initiation: first Viral Suppression to <400 copies/mL (VS), maintaining first VS, Immunocompetence (IC) - stage 1, CDC Immunological Classification - and mortality.
Results:
190 children started cART before one year of age, at an average age of 4.3 months (Standard deviation: ±2.5 months), of whom 45.3% were immunocompetent; 66.8% on nevirapine (NVP)-based versus ritonavir-boosted lopinavir (LPV/r)-based regimens; 37.9% with running water at home. At 10 years of cART initiation, outcomes probabilities estimates were: 22.0% of death mostly in the first 2 years and mainly due to advanced HIV disease, 72.0% of first VS achieved; 70.0% and 50.4% of first VS maintained considering children with first VS achieved and all the study participants, respectively; immunocompetent children increased to 88.6%. Being immunocompetent at cART initiation and receiving LPV/r-based regimens (versus NVP-based ones) over time were significantly associated with maintaining VS.
Conclusion:
Long term efficacy of early cART in children with perinatal HIV was mainly impaired by high mortality during initial phase. Screening strategies, even community-based, for early detecting HIV in exposed infants before advanced HIV disease had set up, should be implemented.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

